Distinctive neoplasms characterised by specific chromosomal translocations comprise a significant proportion of paediatric renal cell carcinomas

References

• Kovacs G, Akhtar M, Beckwith JB, et al. The Heidelberg classification of renal cell tumors. J Pathol 1997; 183: 131–3.
   PubMed Web of Science ®Google Scholar
• Storkel S, Eble JN, Adlakha K, et al. Classification of renal cell carcinoma. Cancer 1997; 80: 987–9.
   PubMed Web of Science ®Google Scholar
• Reuter YE, Presti JC. Contemporary approach to the classification of renal epithelial tumors. Semin Oncol 2000; 27: 124–37.
   PubMed Web of Science ®Google Scholar
• Beckwith JB. Renal neoplasms of childhood. In: Sternberg SS, editor. Diagnostic Surgical Pathology. 3rd ed. Philadelphia: Lippincott Willimas & Wilkins, 1999; 1825–52.
   Google Scholar
• Meideros LJ, Palmedo G, Krigman HR, Kovacs G, Beckwith JB. Oncocytoid renal cell carcinoma after neuroblastoma. A report of four cases of a distinct clinicopathologic entity. Am J Surg Pathol 1999; 23: 772–80.
   Google Scholar
• Davis CJ, Mostofi FK, Sesterhenn IA. Renal medullary carcinoma: the seventh sickle cell nephropathy. Am J Surg Pathol 1995; 19: 1–11.
   Google Scholar
• Allsbrook WC, Boswell WC, Takahashi H, et al. Recurrent renal cell carcinoma arising in Wilms' tumor. Cancer 1991; 67: 690–5.
   PubMed Web of Science ®Google Scholar
• Arroyo MR, Green DM, Perlman EJ, Beckwith JB, Argani P. The spectrum of metanephric adenofibroma and related lesions. Clinico-pathologic study of 25 cases from the National Wilms' Tumor Pathology Center. Am J Surg Pathol 2001; 24: 433–44.
   Google Scholar
• Sidhar SK, Clark J, Gill S, et al. The t(X;1) (p11.2;q21.2) translocation in papillary renal cell carcinoma fuses a novel gene PRCC to the TFE3 transcription factor gene. Hum Mol Genet 1996; 5: 1333–8.
   Google Scholar
• Weterman MAJ, Wilbrink M, Geurts van Kessel A. Fusion of the transcription factor TFE3 gene to a novel gene, PRCC, in t(X;1)(p11.2;q21)-positive papillary renal cell carcinomas. Proc Natl Acad Sci USA 1996; 93: 15294–8.
   Google Scholar
• Clark J, Lu Y-J, Sidhar SK, et al. Fusion of splicing factor genes PSF and Non0 (p54nrb) to the TFE3 gene in papillary renal cell carcinoma. Oncogene 1997; 15: 2233–9.
   Google Scholar
• Hernandez-Marti MJ, Orellana-Alonso C, Badia-Garrabou L, Miralles AV, Paradis-Alos A. Renal adenocarcinoma in an 8-year-old child, with a t(X;17)(p11.2;q25). Cancer Genet Cytogenet 1995; 83: 82–3.
   PubMedGoogle Scholar
• Carcao MD, Taylor GP, Greenberg ML, et al. Renal cell carcinoma in children. A different disorder from its adult counterpart? Med Pediatr Oncol 1998; 31: 153–8.
   PubMedGoogle Scholar
• Heimann P, Devalck C, Debusscher C, Sariban E, Vamos E. Alveolar soft-part sarcoma. Further evidence by FISH for the involvement of chromosome band 17q25. Genes, Chromosomes Cancer 1998; 23: 194–7.
   Google Scholar
• Tomlinson GE, Nisen PD, Timmons CF, Schneider NR. Cytogenetics of a renal cell carcinoma in a 17-month-old child. Evidence for Xp11.2 as a recurring breakpoint. Cancer Genet Cytogenet 1991; 57: 11–17.
   PubMedGoogle Scholar
• Ladanyi M, Lui MY, Antonescu CR, et al. The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25. Oncogene 2001; 20: 48–57.
   PubMed Web of Science ®Google Scholar
• Argani P, Antonescu CR, Illei PB, et al. Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma. A distinctive tumor entity previously included among renal cell carcinomas of children and adolescents. Am J Pathol 2001; 159: 179–92.
   Google Scholar
• Heimann P, El Housni H, Ogur G, et al. Fusion of a novel gene, RCC1 7, to the TFE3 gene in t(X;17)(p11.2;q25.3)-bearing papillary renal cell carcinomas. Cancer Res 2001; 61: 4130–5.
   PubMed Web of Science ®Google Scholar
• Argani P, Ladanyi M. Xpl 1-translocation carcinomas. In: Eble JN, Sauter G, Epstein J, Sesterhenn I, editors. Pathology and Genetics of Tumors of the Urinary System & Male Genital Organs. Lyon, France: IARC (in press, 2003).
   Google Scholar
• Chian-Garcia CA, Torres-Cabala CA, Eyler R, Linehan WM, Merino MJ. Renal cell carcinoma in children and young adults: a clinicopathologic and immunohistochemical study of 14 cases. Mod Pathol 2003; 16: 145A. (abstract)
   Google Scholar
• Bruder E, Passera 0, Harms D, et al. Morphologic and molecular characterization of renal cell carcinoma in children and young adults. Mod Pathol 2003; 16: 143A. (abstract)
   Google Scholar
• Renshaw AA, Granter SR, Fletcher JA, et al. Renal cell carcinomas in children and young adults: increased incidence of papillary architec-ture and unique subtypes. Am J Surg Pathol 1999; 23: 795–802.
   PubMed Web of Science ®Google Scholar
• Argani P, Antonescu CR, Couturier J, et al. PRCC-TFE3 renal carcinomas. Morphologic, immunohistochemical, ultrastructural, and molecular analysis of an entity associated with the t(X;1)(p11.2;q21). Am J Surg Pathol 2002; 26: 1553–66.
   Google Scholar
• Meloni AM, Dobbs RM, Pontes JE, Sandberg AA. Translocation (X;1) in papillary renal cell carcinoma. A new cytogenetic subtype. Cancer Genet Cytogenet 1993; 65: 1–6.
   PubMedGoogle Scholar
• Perot C, Bougaran J, Boccon-Gibod L, et al. Two new cases of papillary renal cell carcinoma with t(X;1)(p11;q21) in females. Cancer Genet Cytogenet 1999; 110: 54–6.
   Google Scholar
• Argani P, Lal P, Hutchinson B, et al. Aberrant nuclear immuno-reactivity for TFE3 in neoplasms with TFE3 gene fusions: a sensitive and specific immunohistochemical assay. Am J Surg Pathol 2003; 27: 750–61.
   PubMed Web of Science ®Google Scholar
• Skalsky YM, Ajuh PM, Parker C, et al. PRCC, the commonest TFE3 fusion partner in papillary renal carcinoma is associated with pre-mRNA splicing factors. Oncogene 1999; 20: 178–87.
   Web of Science ®Google Scholar
• Weterman MAJ, von Groningen JJM, Jansen A, et al. Nuclear localization and transactivating capacities of the papillary renal cell carcinoma-associated TFE3 and PRCC (fusion) proteins. Oncogene 2000; 19: 69–74.
   PubMed Web of Science ®Google Scholar
• Weterman MAJ, van Groningen ii, Tertoolen L, Geurts van Kessel A. Impairment of MAD2B-PRCC interaction in mitotic checkpoint defective t(X;1)-positive renal cell carcinomas. Proc Natl Acad Sci USA 2001; 98: 13 808–13.
   Google Scholar
• Argani P, Lui MY, Couturier J, et al. Cloning of a novel CLTC-TFE3 gene fusion in pediatric renal adenocarcinoma with t(X;17)(p11.2;q23). Oncogene 2003; 22: 5374–8.
   PubMed Web of Science ®Google Scholar
• Bridge JA, Kanamori M, Ma Z, et al. Fusion of the ALK gene to the clathrin heavy chain gene, CLTC, in inflammatory myofibroblastic tumor. Am J Pathol 2001; 159: 411–5.
   PubMed Web of Science ®Google Scholar
• Touriol C, Greenland C, Lament L, et al. Further demonstration of the diversity of chromosomal changes involving 2p23 in ALK-positive lymphoma: 2 cases expressing ALK kinase fused to CLTCL (clathrin chain polypeptide-like). Blood 2000; 95: 3204–7.
   PubMed Web of Science ®Google Scholar
• Dijkhuizen T, van den Berg E, Storkel S, et al. Two cases of renal cell carcinoma, clear cell type, revealing a t(6;11)(p21;q13). Cancer Genet Cytogenet 1996; 91: 141 (abstract)
   Google Scholar
• Argani P, Hawkins A, Griffin CA, et al. A distinctive pediatric renal neoplasm characterized by epithelioid morphology, basement membrane production, focal HM-B45 immunoreactivity, and t(6; 11)(p21.1; q12) chromosome translocation. Am J Pathol 2001; 158: 2089–96.
   PubMed Web of Science ®Google Scholar
• Yeh Y, Vargas S, Fletcher JA, Perez Atayde AR. Distinctive chromosomal translocations in pediatric renal cell carcinoma. Mod Pathol 2002; 15: 7P (abstract).
   Google Scholar
• Davis II, His B-L, Arroyo JD, et al. Cloning of a novel Alpha-TFEB fusion in renal tumors harboring the t(6;11)(p21;q12) chromosome translocation. Proc Natl Acad Sci USA 2003; 100: 6051–6.
   Google Scholar
• Kuiper RP, Schepens M, Thijssen J, et al. Upregulation of the transcription factor TFEB in t(6;11)(p21;q13)-positive renal cell carcinomas due to promoter substitution. Hum Mol Genet 2003; 12: 1661–9.
   PubMed Web of Science ®Google Scholar
• Argani P, Hutchinson B, Bridge J, Reuter V, Ladanyi M. Aberrant nuclear immunoreactivity for TFEB is a specific marker of renal tumors bearing the t(6;11)(p11.2;q12) (submitted).
   Google Scholar
• Chang KL, Folpe AL. Diagnostic utility of microphthalmia transcription factor in malignant melanoma and other tumors. Adv Anat Pathol 2001; 8: 273–5.
   PubMed Web of Science ®Google Scholar
• Hemesath Ti, Steingrimsson E, McGill G, et al. Microphthalmia, a critical factor in melanocytic development, defines a discrete transcription factor family. Genes & Development 1994; 8: 2770–80.
   PubMed Web of Science ®Google Scholar
• Steingrimsson E, Tessarollo L, Reid SW, Jenkins NA, Copeland NG. The bHLH-Zip transcription factor Tfeb is essential for placental vascularization. Development 1998; 125: 4607–16.
   Google Scholar
• Fisher DE, Carr CS, Parent LA, Sharp PA. TFEB has DNA-binding and oligomerization properties of a unique helix-loop-helix/leucine-zipper family. Genes & Development 1991; 5: 2342–52.
   PubMed Web of Science ®Google Scholar
• Quezado M, Benjamin DR, Tsokos M. EWS/FL/-1 fusion transcripts in three peripheral primitive neuroectodermal tumors of the kidney. Hum Pathol 1997; 28: 767–71.
   Google Scholar
• Parham DM, Roloson GJ, Feely M, et al. Primary malignant neuroepithelial tumors of the kidney. A clinicopathologic analysis of 146 adult and pediatric cases from the National Wilms' Tumor Study Group Pathology Center. Am J Surg Pathol 2001; 25: 133–46.
   Google Scholar
• Argani P, Faria PA, Epstein JI, et al. Primary renal synovial sarcoma. Morphologic and molecular delineation of an entity previously included among embryonal sarcomas of the kidney. Am J Surg Pathol 2000; 24: 1087–96.
   Google Scholar
• Kim D-W, Sohn JH, Lee MC, et al. Primary synovial sarcoma of the kidney. Am J Surg Pathol 2000; 24: 1097–104.
   PubMed Web of Science ®Google Scholar
• Knezevich SR, Garnett MJ, Pysher Ti, et al. ETV6-NTRK3 gene fusions and trisomy 11 establish a histogenetic link between mesoblastic nephroma and congenital fibrosarcoma. Cancer Res 1998; 58: 5046–8.
   PubMed Web of Science ®Google Scholar
• Rubin BP, Chen CJ, Morgan TW, et al. Congenital mesoblastic nephroma t(12;15) is associated with ETV6-NTRK3 gene fusion: cytogenetic and molecular relationship to congenital (infantile) fibrosarcoma. Am J Pathol 1998; 153: 1451–8.
   PubMed Web of Science ®Google Scholar
• Rubin BP, Fletcher JA, Renshaw AA. Clear cell sarcoma of soft parts: report of a case primary in the kidney with cytogenetic confirmation. Am J Surg Pathol 1999; 23: 589–94.
   Google Scholar